Haleon plc Stock Nyse

Equities

HLN

US4055521003

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-07-11 pm EDT 5-day change 1st Jan Change
8.8 USD +0.80% Intraday chart for Haleon plc +4.02% +6.93%
Sales 2024 * 11.42B 14.74B Sales 2025 * 11.87B 15.33B Capitalization 30.64B 39.55B
Net income 2024 * 1.48B 1.92B Net income 2025 * 1.69B 2.18B EV / Sales 2024 * 3.36 x
Net Debt 2024 * 7.74B 10B Net Debt 2025 * 6.99B 9.03B EV / Sales 2025 * 3.17 x
P/E ratio 2024 *
21.1 x
P/E ratio 2025 *
18.5 x
Employees 25,408
Yield 2024 *
1.84%
Yield 2025 *
2.11%
Free-Float 81.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.80%
1 week+4.02%
Current month+6.54%
1 month+5.77%
3 months+7.71%
6 months+1.50%
Current year+6.93%
More quotes
1 week
8.49
Extreme 8.49
8.82
1 month
8.25
Extreme 8.245
8.82
Current year
7.89
Extreme 7.89
8.82
1 year
7.70
Extreme 7.695
8.96
3 years
5.59
Extreme 5.59
9.05
5 years
5.59
Extreme 5.59
9.05
10 years
5.59
Extreme 5.59
9.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21-07-21
Director of Finance/CFO 52 21-11-30
Chief Tech/Sci/R&D Officer - 21-12-15
Members of the board TitleAgeSince
Director/Board Member - 22-07-17
Director/Board Member 64 22-07-17
Director/Board Member 57 22-07-17
More insiders
Date Price Change Volume
24-07-11 8.8 +0.80% 3,216,249
24-07-10 8.73 +1.39% 8,889,116
24-07-09 8.61 +1.41% 3,717,486
24-07-08 8.49 +0.24% 2,580,072
24-07-05 8.47 +0.12% 2,462,828

Delayed Quote Nyse, July 11, 2024 at 04:00 pm EDT

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.355 GBP
Average target price
3.637 GBP
Spread / Average Target
+8.41%
Consensus